GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Skystar Bio-Pharmaceutical Co (FRA:GNJC) » Definitions » Cyclically Adjusted PB Ratio

Skystar Bio-Pharmaceutical Co (FRA:GNJC) Cyclically Adjusted PB Ratio : (As of Jun. 23, 2024)


View and export this data going back to . Start your Free Trial

What is Skystar Bio-Pharmaceutical Co Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Skystar Bio-Pharmaceutical Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Skystar Bio-Pharmaceutical Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Skystar Bio-Pharmaceutical Co Cyclically Adjusted PB Ratio Chart

Skystar Bio-Pharmaceutical Co Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Skystar Bio-Pharmaceutical Co Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Skystar Bio-Pharmaceutical Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - General subindustry, Skystar Bio-Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Skystar Bio-Pharmaceutical Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Skystar Bio-Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Skystar Bio-Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.



Skystar Bio-Pharmaceutical Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Skystar Bio-Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2014 is calculated as:

For example, Skystar Bio-Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Sep. 2014 was:

Adj_Book=Book Value per Share/CPI of Sep. 2014 (Change)*Current CPI (Sep. 2014)
=12.501/98.9000*98.9000
=12.501

Current CPI (Sep. 2014) = 98.9000.

Skystar Bio-Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
200412 1.338 74.488 1.777
200503 -0.460 75.597 -0.602
200506 -0.532 74.618 -0.705
200509 -0.595 75.290 -0.782
200512 2.706 75.666 3.537
200603 2.762 76.340 3.578
200606 2.933 76.034 3.815
200609 3.356 76.413 4.344
200612 2.950 77.793 3.750
200703 4.396 78.884 5.511
200706 4.466 79.357 5.566
200709 4.742 81.276 5.770
200712 3.301 82.911 3.938
200803 3.345 85.485 3.870
200806 3.666 85.058 4.263
200809 4.646 85.057 5.402
200812 5.272 83.956 6.210
200903 5.491 84.457 6.430
200906 5.096 83.615 6.028
200909 9.388 84.369 11.005
200912 5.291 85.386 6.128
201003 5.942 86.316 6.808
201006 6.835 85.886 7.871
201009 7.222 87.267 8.185
201012 7.546 89.289 8.358
201103 7.356 91.154 7.981
201106 7.415 91.612 8.005
201109 8.644 92.711 9.221
201112 9.349 92.885 9.954
201203 9.573 94.367 10.033
201206 10.419 93.495 11.021
201209 10.419 94.482 10.906
201212 9.641 95.237 10.012
201303 9.896 96.372 10.156
201306 10.241 95.984 10.552
201309 10.524 97.332 10.694
201312 10.597 97.624 10.736
201403 10.502 98.600 10.534
201406 10.985 98.200 11.063
201409 12.501 98.900 12.501

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Skystar Bio-Pharmaceutical Co  (FRA:GNJC) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Skystar Bio-Pharmaceutical Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Skystar Bio-Pharmaceutical Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Skystar Bio-Pharmaceutical Co (FRA:GNJC) Business Description

Traded in Other Exchanges
N/A
Address
No. 48 Keji Road, 4/F Building B, Chuangye Square, Gaoxin District, Xian, Shaanxi Province, CHN
Skystar Bio-Pharmaceutical Co is a holding company. Through its subsidiaries, it is engaged in the research, development, production, marketing, and sales of veterinary healthcare and medical care products in the People's Republic of China. The company provides individually packaged animal wellness and pharmaceutical products for retail sale. It generates revenue from the sales of four product lines namely, veterinary medications, micro-organism, feed additives, and vaccines. The firm develops, manufactures, packages and distributes vaccines; Western medicines, Traditional Chinese Medicine; topicals, supplements, probiotics; diagnostic kits and animal nutrition supplements for poultry, livestock, marine aquaculture and domesticated pets.

Skystar Bio-Pharmaceutical Co (FRA:GNJC) Headlines

No Headlines